

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nucleoside transmembrane transport (GO:1901642) | 6.06382499 |
| 2 | interkinetic nuclear migration (GO:0022027) | 5.87605228 |
| 3 | alpha-linolenic acid metabolic process (GO:0036109) | 5.39227728 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.34816041 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.34816041 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.30199669 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 5.30199669 |
| 8 | muscle filament sliding (GO:0030049) | 5.20318307 |
| 9 | actin-myosin filament sliding (GO:0033275) | 5.20318307 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.12649302 |
| 11 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.02739832 |
| 12 | aromatic amino acid family catabolic process (GO:0009074) | 4.99975057 |
| 13 | striatum development (GO:0021756) | 4.99598281 |
| 14 | cysteine metabolic process (GO:0006534) | 4.89199950 |
| 15 | bile acid biosynthetic process (GO:0006699) | 4.83119232 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.77391018 |
| 17 | kynurenine metabolic process (GO:0070189) | 4.76188165 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 4.76075226 |
| 19 | tryptophan catabolic process (GO:0006569) | 4.69979394 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 4.69979394 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 4.69979394 |
| 22 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 4.68528489 |
| 23 | tryptophan metabolic process (GO:0006568) | 4.68270852 |
| 24 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.64204898 |
| 25 | lysine catabolic process (GO:0006554) | 4.63231873 |
| 26 | lysine metabolic process (GO:0006553) | 4.63231873 |
| 27 | positive regulation of action potential (GO:0045760) | 4.61457935 |
| 28 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.57940718 |
| 29 | protein carboxylation (GO:0018214) | 4.56223138 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.56223138 |
| 31 | complement activation, alternative pathway (GO:0006957) | 4.50323120 |
| 32 | sulfur amino acid catabolic process (GO:0000098) | 4.43750819 |
| 33 | urea cycle (GO:0000050) | 4.42139941 |
| 34 | urea metabolic process (GO:0019627) | 4.42139941 |
| 35 | actin-mediated cell contraction (GO:0070252) | 4.37529901 |
| 36 | regulation of protein activation cascade (GO:2000257) | 4.35247714 |
| 37 | high-density lipoprotein particle remodeling (GO:0034375) | 4.29085565 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 4.27559492 |
| 39 | myofibril assembly (GO:0030239) | 4.22181232 |
| 40 | regulation of fibrinolysis (GO:0051917) | 4.21815129 |
| 41 | regulation of relaxation of muscle (GO:1901077) | 4.18965934 |
| 42 | regulation of skeletal muscle contraction (GO:0014819) | 4.15614454 |
| 43 | platelet dense granule organization (GO:0060155) | 4.15127411 |
| 44 | regulation of complement activation (GO:0030449) | 4.09257945 |
| 45 | cellular glucuronidation (GO:0052695) | 4.08506420 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.06845735 |
| 47 | sarcomere organization (GO:0045214) | 4.06558663 |
| 48 | homocysteine metabolic process (GO:0050667) | 4.06372899 |
| 49 | outflow tract septum morphogenesis (GO:0003148) | 4.04310937 |
| 50 | neuronal action potential (GO:0019228) | 4.03664405 |
| 51 | bile acid metabolic process (GO:0008206) | 4.00957278 |
| 52 | nitrogen cycle metabolic process (GO:0071941) | 3.98012872 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 3.94466216 |
| 54 | negative regulation of sterol transport (GO:0032372) | 3.94466216 |
| 55 | response to inactivity (GO:0014854) | 3.94198096 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 3.92493049 |
| 57 | urate metabolic process (GO:0046415) | 3.89559990 |
| 58 | reverse cholesterol transport (GO:0043691) | 3.84220571 |
| 59 | glycine metabolic process (GO:0006544) | 3.79201899 |
| 60 | regulation of cholesterol homeostasis (GO:2000188) | 3.76982723 |
| 61 | regulation of triglyceride catabolic process (GO:0010896) | 3.76581457 |
| 62 | drug transmembrane transport (GO:0006855) | 3.74126889 |
| 63 | behavioral response to nicotine (GO:0035095) | 3.72326658 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 3.72309793 |
| 65 | phospholipid efflux (GO:0033700) | 3.70134268 |
| 66 | phospholipid homeostasis (GO:0055091) | 3.68928430 |
| 67 | nucleoside transport (GO:0015858) | 3.66900881 |
| 68 | plasma lipoprotein particle remodeling (GO:0034369) | 3.65112360 |
| 69 | protein-lipid complex remodeling (GO:0034368) | 3.65112360 |
| 70 | macromolecular complex remodeling (GO:0034367) | 3.65112360 |
| 71 | aromatic amino acid family metabolic process (GO:0009072) | 3.65047206 |
| 72 | glucuronate metabolic process (GO:0019585) | 3.64809862 |
| 73 | uronic acid metabolic process (GO:0006063) | 3.64809862 |
| 74 | cellular modified amino acid catabolic process (GO:0042219) | 3.62710810 |
| 75 | ethanol oxidation (GO:0006069) | 3.61944973 |
| 76 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.60108298 |
| 77 | regulation of cholesterol esterification (GO:0010872) | 3.58975293 |
| 78 | skeletal muscle adaptation (GO:0043501) | 3.57857633 |
| 79 | acylglycerol homeostasis (GO:0055090) | 3.57649708 |
| 80 | triglyceride homeostasis (GO:0070328) | 3.57649708 |
| 81 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.57248371 |
| 82 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.56710665 |
| 83 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.54865376 |
| 84 | skeletal muscle contraction (GO:0003009) | 3.54662369 |
| 85 | tyrosine metabolic process (GO:0006570) | 3.53034220 |
| 86 | regulation of glucokinase activity (GO:0033131) | 3.50948450 |
| 87 | regulation of hexokinase activity (GO:1903299) | 3.50948450 |
| 88 | thrombin receptor signaling pathway (GO:0070493) | 3.50869771 |
| 89 | benzene-containing compound metabolic process (GO:0042537) | 3.50577787 |
| 90 | alpha-amino acid catabolic process (GO:1901606) | 3.48963525 |
| 91 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.48755433 |
| 92 | fibrinolysis (GO:0042730) | 3.47027203 |
| 93 | reflex (GO:0060004) | 3.45141177 |
| 94 | valine metabolic process (GO:0006573) | 3.44409806 |
| 95 | 2-oxoglutarate metabolic process (GO:0006103) | 3.42082835 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 3.41703775 |
| 97 | response to nitrosative stress (GO:0051409) | 3.38622414 |
| 98 | positive regulation of lipid catabolic process (GO:0050996) | 3.36893249 |
| 99 | cholesterol efflux (GO:0033344) | 3.36148040 |
| 100 | fatty acid transmembrane transport (GO:1902001) | 3.35947901 |
| 101 | adult heart development (GO:0007512) | 3.35814708 |
| 102 | lipoprotein metabolic process (GO:0042157) | 3.35367198 |
| 103 | cardiac myofibril assembly (GO:0055003) | 3.35034648 |
| 104 | regulation of action potential (GO:0098900) | 3.34560153 |
| 105 | indolalkylamine metabolic process (GO:0006586) | 3.32812550 |
| 106 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.32323880 |
| 107 | glutamate metabolic process (GO:0006536) | 3.31589868 |
| 108 | protein-lipid complex assembly (GO:0065005) | 3.30340851 |
| 109 | glomerular filtration (GO:0003094) | 3.29379384 |
| 110 | bile acid and bile salt transport (GO:0015721) | 3.28652676 |
| 111 | low-density lipoprotein particle clearance (GO:0034383) | 3.28137907 |
| 112 | serotonin metabolic process (GO:0042428) | 3.25225750 |
| 113 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.25216681 |
| 114 | drug catabolic process (GO:0042737) | 3.25030501 |
| 115 | primary amino compound metabolic process (GO:1901160) | 3.23991988 |
| 116 | striated muscle contraction (GO:0006941) | 3.23483841 |
| 117 | creatine metabolic process (GO:0006600) | 3.23285517 |
| 118 | cellular amino acid catabolic process (GO:0009063) | 3.22604656 |
| 119 | fatty acid oxidation (GO:0019395) | 3.21639075 |
| 120 | acetyl-CoA metabolic process (GO:0006084) | 3.21546276 |
| 121 | serine family amino acid biosynthetic process (GO:0009070) | 3.20880943 |
| 122 | carnitine metabolic process (GO:0009437) | 3.20573341 |
| 123 | cholesterol homeostasis (GO:0042632) | 3.20407040 |
| 124 | fatty acid beta-oxidation (GO:0006635) | 3.20269585 |
| 125 | epoxygenase P450 pathway (GO:0019373) | 3.20042876 |
| 126 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.19634970 |
| 127 | sterol homeostasis (GO:0055092) | 3.19294771 |
| 128 | regulation of striated muscle contraction (GO:0006942) | 3.17887663 |
| 129 | response to muscle activity (GO:0014850) | 3.17550553 |
| 130 | relaxation of cardiac muscle (GO:0055119) | 3.16929281 |
| 131 | acute-phase response (GO:0006953) | 3.14433582 |
| 132 | lipid oxidation (GO:0034440) | 3.14206593 |
| 133 | opsonization (GO:0008228) | 3.13464929 |
| 134 | drug transport (GO:0015893) | 3.11686407 |
| 135 | ubiquinone biosynthetic process (GO:0006744) | 3.09470117 |
| 136 | carnitine shuttle (GO:0006853) | 3.06726903 |
| 137 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.06327428 |
| 138 | short-chain fatty acid metabolic process (GO:0046459) | 3.06220185 |
| 139 | regulation of cholesterol metabolic process (GO:0090181) | 3.04653923 |
| 140 | regulation of energy homeostasis (GO:2000505) | 3.04595044 |
| 141 | regulation of sequestering of triglyceride (GO:0010889) | 3.03096394 |
| 142 | aldehyde catabolic process (GO:0046185) | 3.02342080 |
| 143 | indole-containing compound metabolic process (GO:0042430) | 3.01700110 |
| 144 | glandular epithelial cell development (GO:0002068) | 3.01102358 |
| 145 | adrenergic receptor signaling pathway (GO:0071875) | 3.00650864 |
| 146 | aspartate family amino acid catabolic process (GO:0009068) | 3.00108426 |
| 147 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.99869394 |
| 148 | cellular biogenic amine catabolic process (GO:0042402) | 2.99463133 |
| 149 | amine catabolic process (GO:0009310) | 2.99463133 |
| 150 | nucleus localization (GO:0051647) | 2.97059695 |
| 151 | positive regulation of heart rate (GO:0010460) | 2.96679768 |
| 152 | actin filament-based movement (GO:0030048) | 2.93695171 |
| 153 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.90502502 |
| 154 | neuronal action potential propagation (GO:0019227) | 2.89842645 |
| 155 | actomyosin structure organization (GO:0031032) | 2.86125785 |
| 156 | response to caffeine (GO:0031000) | 2.85840604 |
| 157 | striated muscle atrophy (GO:0014891) | 2.85146150 |
| 158 | ubiquinone metabolic process (GO:0006743) | 2.84099902 |
| 159 | regulation of the force of heart contraction (GO:0002026) | 2.82979540 |
| 160 | muscle contraction (GO:0006936) | 2.81904345 |
| 161 | cardiac muscle contraction (GO:0060048) | 2.81309649 |
| 162 | renal filtration (GO:0097205) | 2.79660914 |
| 163 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.79230831 |
| 164 | retinoic acid receptor signaling pathway (GO:0048384) | 2.77053089 |
| 165 | regulation of hippo signaling (GO:0035330) | 2.76277046 |
| 166 | positive regulation of protein kinase C signaling (GO:0090037) | 2.76271019 |
| 167 | intestinal cholesterol absorption (GO:0030299) | 2.76064273 |
| 168 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.75297963 |
| 169 | cellular response to ATP (GO:0071318) | 2.74973554 |
| 170 | regulation of actin filament-based movement (GO:1903115) | 2.72717855 |
| 171 | alanine transport (GO:0032328) | 2.72004139 |
| 172 | skeletal muscle tissue regeneration (GO:0043403) | 2.71147813 |
| 173 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.70198920 |
| 174 | embryonic digestive tract development (GO:0048566) | 2.70085521 |
| 175 | cardiac muscle cell differentiation (GO:0055007) | 2.68923172 |
| 176 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.68600800 |
| 177 | regulation of cell communication by electrical coupling (GO:0010649) | 2.63677455 |
| 178 | regulation of sarcomere organization (GO:0060297) | 2.63245606 |
| 179 | muscle system process (GO:0003012) | 2.62962828 |
| 180 | cardiac muscle hypertrophy (GO:0003300) | 2.59410352 |
| 181 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.58261856 |
| 182 | quinone biosynthetic process (GO:1901663) | 2.57211991 |
| 183 | muscle tissue morphogenesis (GO:0060415) | 2.56463276 |
| 184 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.55900070 |
| 185 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.55115923 |
| 186 | growth hormone receptor signaling pathway (GO:0060396) | 2.54342371 |
| 187 | regulation of cardiac muscle contraction (GO:0055117) | 2.53911301 |
| 188 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.51034306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.51799524 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.98493179 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.48573157 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 5.12908763 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.82995157 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.60070831 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.81366345 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.77726029 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.32115429 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.20004176 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.99147813 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.92380363 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.88418911 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.82566556 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.79668309 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.73604305 |
| 17 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.67907378 |
| 18 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.50269469 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.49369033 |
| 20 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.29439072 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24809829 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.24630718 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.18754512 |
| 24 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.11543462 |
| 25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.08339245 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.07309735 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.02185771 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.99343341 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.91367973 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.89211658 |
| 31 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.88972216 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.84610025 |
| 33 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.78737419 |
| 34 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.78443256 |
| 35 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.76424424 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71966052 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.71899967 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71832158 |
| 39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.70900163 |
| 40 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.70275559 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.67029205 |
| 42 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.66662169 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.63413144 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61303407 |
| 45 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.60931547 |
| 46 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.60673544 |
| 47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.59151691 |
| 48 | STAT3_23295773_ChIP-Seq_U87_Human | 1.58064573 |
| 49 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.57595932 |
| 50 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.56018450 |
| 51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55957212 |
| 52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.54076966 |
| 53 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.51114104 |
| 54 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49016107 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47592637 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.47142016 |
| 57 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46601888 |
| 58 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.46590313 |
| 59 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.45817026 |
| 60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45599870 |
| 61 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45180597 |
| 62 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.43105025 |
| 63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43073377 |
| 64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.43031940 |
| 65 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.42839340 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.41774555 |
| 67 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.40850004 |
| 68 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.40789671 |
| 69 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40009319 |
| 70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39772550 |
| 71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.39126647 |
| 72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.38851008 |
| 73 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.38622703 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37376910 |
| 75 | TCF4_23295773_ChIP-Seq_U87_Human | 1.37142792 |
| 76 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36258255 |
| 77 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.35670482 |
| 78 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.35597278 |
| 79 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32329111 |
| 80 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.32163939 |
| 81 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.30843819 |
| 82 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.30668039 |
| 83 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30299152 |
| 84 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30246639 |
| 85 | EWS_26573619_Chip-Seq_HEK293_Human | 1.29840022 |
| 86 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27811291 |
| 87 | MYC_22102868_ChIP-Seq_BL_Human | 1.27003532 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.25145027 |
| 89 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24325527 |
| 90 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.23035572 |
| 91 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.21533137 |
| 92 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20977987 |
| 93 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20753982 |
| 94 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20104764 |
| 95 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19991838 |
| 96 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19858807 |
| 97 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.19424882 |
| 98 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19047738 |
| 99 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.18835336 |
| 100 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.18179701 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16535199 |
| 102 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.13354490 |
| 103 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13026484 |
| 104 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.12745669 |
| 105 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.12429193 |
| 106 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12275925 |
| 107 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11723564 |
| 108 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.11391240 |
| 109 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.11332525 |
| 110 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.11332525 |
| 111 | RXR_22108803_ChIP-Seq_LS180_Human | 1.10592300 |
| 112 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09645959 |
| 113 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09589700 |
| 114 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.09417885 |
| 115 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09115281 |
| 116 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09038028 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08223857 |
| 118 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.07720741 |
| 119 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.05822363 |
| 120 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05680791 |
| 121 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05315009 |
| 122 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.05256450 |
| 123 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05256450 |
| 124 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04994440 |
| 125 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04870217 |
| 126 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04132730 |
| 127 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03953740 |
| 128 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03380784 |
| 129 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.03118529 |
| 130 | CJUN_26792858_Chip-Seq_BT549_Human | 1.03015142 |
| 131 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02636119 |
| 132 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02606466 |
| 133 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02408768 |
| 134 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01943786 |
| 135 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.01691702 |
| 136 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01654022 |
| 137 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.01337184 |
| 138 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.01337184 |
| 139 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00545591 |
| 140 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00469742 |
| 141 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99765199 |
| 142 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.99661451 |
| 143 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99558358 |
| 144 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99540143 |
| 145 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99195145 |
| 146 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99136222 |
| 147 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99023708 |
| 148 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98871901 |
| 149 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.98795242 |
| 150 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.98113500 |
| 151 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97728658 |
| 152 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97633314 |
| 153 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97344314 |
| 154 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97176004 |
| 155 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97176004 |
| 156 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96644334 |
| 157 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.95978604 |
| 158 | * MYB_26560356_Chip-Seq_TH1_Human | 0.95115141 |
| 159 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.94961694 |
| 160 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.94114757 |
| 161 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.92300342 |
| 162 | * MAF_26560356_Chip-Seq_TH1_Human | 0.91215060 |
| 163 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91070403 |
| 164 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.90625044 |
| 165 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.87194154 |
| 166 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84540339 |
| 167 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84412781 |
| 168 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.82956070 |
| 169 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.82914484 |
| 170 | MYB_26560356_Chip-Seq_TH2_Human | 0.81898867 |
| 171 | UTX_26944678_Chip-Seq_JUKART_Human | 0.81391528 |
| 172 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81181547 |
| 173 | GATA1_22025678_ChIP-Seq_K562_Human | 0.80286597 |
| 174 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.79497798 |
| 175 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.78740016 |
| 176 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78376315 |
| 177 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.76940196 |
| 178 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.76163345 |
| 179 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.75513873 |
| 180 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.75405593 |
| 181 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75237732 |
| 182 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.74315718 |
| 183 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.73925148 |
| 184 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.72350800 |
| 185 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.72052240 |
| 186 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.71324914 |
| 187 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.69724680 |
| 188 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.68593077 |
| 189 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.68593077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.43852321 |
| 2 | MP0005360_urolithiasis | 5.81233451 |
| 3 | MP0003646_muscle_fatigue | 4.83448082 |
| 4 | MP0005365_abnormal_bile_salt | 4.62068104 |
| 5 | MP0010030_abnormal_orbit_morphology | 4.47335191 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 4.42698376 |
| 7 | MP0004145_abnormal_muscle_electrophysio | 4.10792839 |
| 8 | MP0000569_abnormal_digit_pigmentation | 4.06816216 |
| 9 | MP0005248_abnormal_Harderian_gland | 3.74463910 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 3.62471960 |
| 11 | MP0003252_abnormal_bile_duct | 3.31358019 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 3.13661313 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 3.12890888 |
| 14 | MP0004084_abnormal_cardiac_muscle | 3.10218376 |
| 15 | MP0004036_abnormal_muscle_relaxation | 3.01657380 |
| 16 | MP0003136_yellow_coat_color | 3.01206586 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.72948303 |
| 18 | MP0009840_abnormal_foam_cell | 2.72316434 |
| 19 | MP0004215_abnormal_myocardial_fiber | 2.60857227 |
| 20 | MP0000749_muscle_degeneration | 2.56677242 |
| 21 | MP0002332_abnormal_exercise_endurance | 2.52399701 |
| 22 | MP0000751_myopathy | 2.42523449 |
| 23 | MP0004484_altered_response_of | 2.40721284 |
| 24 | MP0005083_abnormal_biliary_tract | 2.34677798 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 2.33292332 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.32831898 |
| 27 | MP0005332_abnormal_amino_acid | 2.22339813 |
| 28 | MP0005620_abnormal_muscle_contractility | 2.19499145 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 2.10979752 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 2.07512613 |
| 31 | MP0005174_abnormal_tail_pigmentation | 2.06889529 |
| 32 | MP0000609_abnormal_liver_physiology | 2.01847550 |
| 33 | MP0002106_abnormal_muscle_physiology | 1.98763867 |
| 34 | MP0003195_calcinosis | 1.94088038 |
| 35 | MP0008775_abnormal_heart_ventricle | 1.89920079 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.75464358 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.71895983 |
| 38 | MP0001666_abnormal_nutrient_absorption | 1.71326219 |
| 39 | MP0002972_abnormal_cardiac_muscle | 1.70955535 |
| 40 | MP0004087_abnormal_muscle_fiber | 1.64570764 |
| 41 | MP0005369_muscle_phenotype | 1.61703518 |
| 42 | MP0002102_abnormal_ear_morphology | 1.58218381 |
| 43 | MP0005319_abnormal_enzyme/_coenzyme | 1.56943678 |
| 44 | MP0002118_abnormal_lipid_homeostasis | 1.55789103 |
| 45 | MP0002282_abnormal_trachea_morphology | 1.52267064 |
| 46 | MP0005330_cardiomyopathy | 1.50739113 |
| 47 | MP0006138_congestive_heart_failure | 1.50204623 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.49253351 |
| 49 | MP0000747_muscle_weakness | 1.47124569 |
| 50 | MP0002269_muscular_atrophy | 1.45847939 |
| 51 | MP0005171_absent_coat_pigmentation | 1.43726296 |
| 52 | MP0005266_abnormal_metabolism | 1.42039334 |
| 53 | MP0003436_decreased_susceptibility_to | 1.40811950 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.38897147 |
| 55 | MP0000750_abnormal_muscle_regeneration | 1.36412344 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.35014299 |
| 57 | MP0009764_decreased_sensitivity_to | 1.34147315 |
| 58 | MP0001984_abnormal_olfaction | 1.34134201 |
| 59 | MP0003011_delayed_dark_adaptation | 1.33446569 |
| 60 | MP0000759_abnormal_skeletal_muscle | 1.33363900 |
| 61 | MP0008438_abnormal_cutaneous_collagen | 1.32860002 |
| 62 | MP0001544_abnormal_cardiovascular_syste | 1.32330757 |
| 63 | MP0005385_cardiovascular_system_phenoty | 1.32330757 |
| 64 | MP0000598_abnormal_liver_morphology | 1.28984956 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.28113197 |
| 66 | MP0002249_abnormal_larynx_morphology | 1.27274947 |
| 67 | MP0010234_abnormal_vibrissa_follicle | 1.27141967 |
| 68 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.26358643 |
| 69 | MP0000613_abnormal_salivary_gland | 1.25048265 |
| 70 | MP0003186_abnormal_redox_activity | 1.22514157 |
| 71 | MP0003137_abnormal_impulse_conducting | 1.22405414 |
| 72 | MP0003880_abnormal_central_pattern | 1.21835583 |
| 73 | MP0004947_skin_inflammation | 1.20336007 |
| 74 | MP0002971_abnormal_brown_adipose | 1.19336990 |
| 75 | MP0005058_abnormal_lysosome_morphology | 1.17386868 |
| 76 | MP0000230_abnormal_systemic_arterial | 1.16900984 |
| 77 | MP0004142_abnormal_muscle_tone | 1.15344342 |
| 78 | MP0003868_abnormal_feces_composition | 1.13240027 |
| 79 | MP0005595_abnormal_vascular_smooth | 1.11605892 |
| 80 | MP0005451_abnormal_body_composition | 1.10878990 |
| 81 | MP0003566_abnormal_cell_adhesion | 1.10593245 |
| 82 | MP0008469_abnormal_protein_level | 1.08675086 |
| 83 | MP0005464_abnormal_platelet_physiology | 1.07170981 |
| 84 | MP0009763_increased_sensitivity_to | 1.06178687 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 1.04824686 |
| 86 | MP0002136_abnormal_kidney_physiology | 1.04602746 |
| 87 | MP0004085_abnormal_heartbeat | 1.03034339 |
| 88 | MP0005647_abnormal_sex_gland | 1.02907399 |
| 89 | MP0005023_abnormal_wound_healing | 1.02342271 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 1.01527923 |
| 91 | MP0000534_abnormal_ureter_morphology | 0.99777717 |
| 92 | MP0003878_abnormal_ear_physiology | 0.99251205 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 0.99251205 |
| 94 | MP0004510_myositis | 0.98854423 |
| 95 | MP0002127_abnormal_cardiovascular_syste | 0.98422478 |
| 96 | MP0009053_abnormal_anal_canal | 0.98045217 |
| 97 | MP0003950_abnormal_plasma_membrane | 0.97968028 |
| 98 | MP0010368_abnormal_lymphatic_system | 0.97668716 |
| 99 | MP0001764_abnormal_homeostasis | 0.97166058 |
| 100 | MP0003283_abnormal_digestive_organ | 0.95903867 |
| 101 | MP0002254_reproductive_system_inflammat | 0.95187511 |
| 102 | MP0006082_CNS_inflammation | 0.93873471 |
| 103 | MP0005636_abnormal_mineral_homeostasis | 0.92598554 |
| 104 | MP0004043_abnormal_pH_regulation | 0.91122014 |
| 105 | MP0001756_abnormal_urination | 0.90065844 |
| 106 | MP0001853_heart_inflammation | 0.89855633 |
| 107 | MP0002166_altered_tumor_susceptibility | 0.89280796 |
| 108 | MP0002928_abnormal_bile_duct | 0.88841599 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.88584430 |
| 110 | MP0001485_abnormal_pinna_reflex | 0.88188703 |
| 111 | MP0000604_amyloidosis | 0.86646946 |
| 112 | MP0004885_abnormal_endolymph | 0.86556618 |
| 113 | MP0009384_cardiac_valve_regurgitation | 0.85100942 |
| 114 | MP0005076_abnormal_cell_differentiation | 0.84684404 |
| 115 | MP0010630_abnormal_cardiac_muscle | 0.83772559 |
| 116 | MP0005408_hypopigmentation | 0.83739257 |
| 117 | MP0004233_abnormal_muscle_weight | 0.83347381 |
| 118 | MP0001915_intracranial_hemorrhage | 0.81719088 |
| 119 | MP0001845_abnormal_inflammatory_respons | 0.81264919 |
| 120 | MP0004742_abnormal_vestibular_system | 0.80887272 |
| 121 | MP0009278_abnormal_bone_marrow | 0.79573488 |
| 122 | MP0001661_extended_life_span | 0.79475374 |
| 123 | MP0003091_abnormal_cell_migration | 0.78309212 |
| 124 | MP0010307_abnormal_tumor_latency | 0.77870835 |
| 125 | MP0001835_abnormal_antigen_presentation | 0.77009049 |
| 126 | MP0004130_abnormal_muscle_cell | 0.76544468 |
| 127 | MP0000427_abnormal_hair_cycle | 0.76022680 |
| 128 | MP0003959_abnormal_lean_body | 0.75603415 |
| 129 | MP0000685_abnormal_immune_system | 0.74517363 |
| 130 | MP0009642_abnormal_blood_homeostasis | 0.73926001 |
| 131 | MP0009697_abnormal_copulation | 0.72941141 |
| 132 | MP0005397_hematopoietic_system_phenotyp | 0.72224892 |
| 133 | MP0001545_abnormal_hematopoietic_system | 0.72224892 |
| 134 | MP0000372_irregular_coat_pigmentation | 0.71196649 |
| 135 | MP0005253_abnormal_eye_physiology | 0.71142025 |
| 136 | MP0002419_abnormal_innate_immunity | 0.70802878 |
| 137 | MP0005670_abnormal_white_adipose | 0.70660493 |
| 138 | MP0001533_abnormal_skeleton_physiology | 0.70574617 |
| 139 | MP0003828_pulmonary_edema | 0.69947534 |
| 140 | MP0002108_abnormal_muscle_morphology | 0.69364087 |
| 141 | MP0002168_other_aberrant_phenotype | 0.68855016 |
| 142 | MP0009785_altered_susceptibility_to | 0.68551050 |
| 143 | MP0000858_altered_metastatic_potential | 0.67811749 |
| 144 | MP0005666_abnormal_adipose_tissue | 0.67674436 |
| 145 | MP0006036_abnormal_mitochondrial_physio | 0.67206283 |
| 146 | MP0002006_tumorigenesis | 0.66746190 |
| 147 | MP0009765_abnormal_xenobiotic_induced | 0.66580852 |
| 148 | MP0005645_abnormal_hypothalamus_physiol | 0.66489148 |
| 149 | MP0005025_abnormal_response_to | 0.65995512 |
| 150 | MP0005220_abnormal_exocrine_pancreas | 0.65816344 |
| 151 | MP0002060_abnormal_skin_morphology | 0.64169864 |
| 152 | MP0002067_abnormal_sensory_capabilities | 0.63032474 |
| 153 | MP0005166_decreased_susceptibility_to | 0.62846068 |
| 154 | MP0003279_aneurysm | 0.62482970 |
| 155 | MP0003303_peritoneal_inflammation | 0.62201844 |
| 156 | MP0000013_abnormal_adipose_tissue | 0.61498795 |
| 157 | MP0005197_abnormal_uvea_morphology | 0.60485222 |
| 158 | MP0005167_abnormal_blood-brain_barrier | 0.60385824 |
| 159 | MP0001800_abnormal_humoral_immune | 0.60384502 |
| 160 | MP0003724_increased_susceptibility_to | 0.59067495 |
| 161 | MP0002796_impaired_skin_barrier | 0.58998026 |
| 162 | MP0000249_abnormal_blood_vessel | 0.58953805 |
| 163 | MP0000383_abnormal_hair_follicle | 0.58790035 |
| 164 | MP0003045_fibrosis | 0.58535061 |
| 165 | MP0000371_diluted_coat_color | 0.58351155 |
| 166 | MP0002135_abnormal_kidney_morphology | 0.58140057 |
| 167 | MP0001501_abnormal_sleep_pattern | 0.57896441 |
| 168 | MP0010155_abnormal_intestine_physiology | 0.57712386 |
| 169 | MP0005275_abnormal_skin_tensile | 0.57639896 |
| 170 | MP0001216_abnormal_epidermal_layer | 0.55447559 |
| 171 | MP0005334_abnormal_fat_pad | 0.54947915 |
| 172 | MP0008873_increased_physiological_sensi | 0.54062224 |
| 173 | MP0005376_homeostasis/metabolism_phenot | 0.54059446 |
| 174 | MP0002452_abnormal_antigen_presenting | 0.53879680 |
| 175 | MP0002932_abnormal_joint_morphology | 0.53523542 |
| 176 | MP0005000_abnormal_immune_tolerance | 0.52703346 |
| 177 | MP0001881_abnormal_mammary_gland | 0.52292659 |
| 178 | MP0004883_abnormal_blood_vessel | 0.52183327 |
| 179 | MP0002234_abnormal_pharynx_morphology | 0.52116731 |
| 180 | MP0001873_stomach_inflammation | 0.52088137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 6.04799816 |
| 2 | Abnormal pancreas size (HP:0012094) | 5.87608432 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.77090052 |
| 4 | Nemaline bodies (HP:0003798) | 5.70211643 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 5.68107158 |
| 6 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.64745446 |
| 7 | Xanthomatosis (HP:0000991) | 5.52010331 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.36014868 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.18446778 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.80014030 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 4.73385734 |
| 12 | Annular pancreas (HP:0001734) | 4.64573886 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.63598388 |
| 14 | Complement deficiency (HP:0004431) | 4.59254800 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 4.30238591 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 4.26333221 |
| 17 | Exercise-induced myalgia (HP:0003738) | 4.14897079 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.07921937 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 3.97558303 |
| 20 | Bundle branch block (HP:0011710) | 3.95140852 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.91280758 |
| 22 | Epidermoid cyst (HP:0200040) | 3.89674130 |
| 23 | Subaortic stenosis (HP:0001682) | 3.79212325 |
| 24 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.79212325 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 3.72216346 |
| 26 | Exercise-induced muscle cramps (HP:0003710) | 3.70503652 |
| 27 | Hypolipoproteinemia (HP:0010981) | 3.70371585 |
| 28 | Joint hemorrhage (HP:0005261) | 3.67739755 |
| 29 | Sudden death (HP:0001699) | 3.63883750 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.63149204 |
| 31 | Large for gestational age (HP:0001520) | 3.61808175 |
| 32 | Abnormality of the calf musculature (HP:0001430) | 3.61123434 |
| 33 | Myocardial infarction (HP:0001658) | 3.57333861 |
| 34 | Abnormality of complement system (HP:0005339) | 3.57204101 |
| 35 | Hyperammonemia (HP:0001987) | 3.53974972 |
| 36 | Heart block (HP:0012722) | 3.52702270 |
| 37 | Asymmetric septal hypertrophy (HP:0001670) | 3.43148997 |
| 38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.41736303 |
| 39 | Muscle fiber splitting (HP:0003555) | 3.41561877 |
| 40 | Fat malabsorption (HP:0002630) | 3.39126545 |
| 41 | EMG: myopathic abnormalities (HP:0003458) | 3.37785008 |
| 42 | Atrioventricular block (HP:0001678) | 3.36787374 |
| 43 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.31979223 |
| 44 | Hypoalphalipoproteinemia (HP:0003233) | 3.31166012 |
| 45 | Abnormality of alanine metabolism (HP:0010916) | 3.25355870 |
| 46 | Hyperalaninemia (HP:0003348) | 3.25355870 |
| 47 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.25355870 |
| 48 | Pancreatic cysts (HP:0001737) | 3.23125168 |
| 49 | Anophthalmia (HP:0000528) | 3.19555976 |
| 50 | Hyperglycinemia (HP:0002154) | 3.19130146 |
| 51 | Bicornuate uterus (HP:0000813) | 3.15171573 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.12653044 |
| 53 | Hyperglycinuria (HP:0003108) | 3.11738486 |
| 54 | Abnormality of the renal cortex (HP:0011035) | 3.10956737 |
| 55 | Abnormal atrioventricular conduction (HP:0005150) | 3.10766017 |
| 56 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.07048012 |
| 57 | Abnormality of glycine metabolism (HP:0010895) | 3.07048012 |
| 58 | Ketosis (HP:0001946) | 3.06891722 |
| 59 | Spastic diplegia (HP:0001264) | 3.05599757 |
| 60 | Esophageal varix (HP:0002040) | 3.03838952 |
| 61 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.02445375 |
| 62 | Atrial fibrillation (HP:0005110) | 3.00686981 |
| 63 | Rimmed vacuoles (HP:0003805) | 2.99668883 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.99232804 |
| 65 | Hypercholesterolemia (HP:0003124) | 2.98306478 |
| 66 | Distal arthrogryposis (HP:0005684) | 2.97001289 |
| 67 | Primary atrial arrhythmia (HP:0001692) | 2.96136089 |
| 68 | Congenital sensorineural hearing impairment (HP:0008527) | 2.95824366 |
| 69 | Tubular atrophy (HP:0000092) | 2.93536926 |
| 70 | Syncope (HP:0001279) | 2.90801547 |
| 71 | Hypoglycemic coma (HP:0001325) | 2.90058344 |
| 72 | Abnormality of methionine metabolism (HP:0010901) | 2.87630366 |
| 73 | Abnormality of purine metabolism (HP:0004352) | 2.86295553 |
| 74 | Abnormality of nucleobase metabolism (HP:0010932) | 2.83647974 |
| 75 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.79828927 |
| 76 | Abnormality of the intrinsic pathway (HP:0010989) | 2.79570565 |
| 77 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.78352816 |
| 78 | Lipoatrophy (HP:0100578) | 2.77397771 |
| 79 | Systemic lupus erythematosus (HP:0002725) | 2.77220099 |
| 80 | Supraventricular tachycardia (HP:0004755) | 2.75516358 |
| 81 | Supraventricular arrhythmia (HP:0005115) | 2.68324228 |
| 82 | Ventricular tachycardia (HP:0004756) | 2.68279056 |
| 83 | Areflexia of lower limbs (HP:0002522) | 2.64928479 |
| 84 | Gout (HP:0001997) | 2.61587151 |
| 85 | Polydipsia (HP:0001959) | 2.60698452 |
| 86 | Abnormal drinking behavior (HP:0030082) | 2.60698452 |
| 87 | Pancreatic fibrosis (HP:0100732) | 2.59676862 |
| 88 | Vascular calcification (HP:0004934) | 2.59244232 |
| 89 | Skin nodule (HP:0200036) | 2.53534263 |
| 90 | Steatorrhea (HP:0002570) | 2.49218834 |
| 91 | Myoglobinuria (HP:0002913) | 2.48616989 |
| 92 | Type II lissencephaly (HP:0007260) | 2.48144366 |
| 93 | Cardiovascular calcification (HP:0011915) | 2.45737327 |
| 94 | Cholecystitis (HP:0001082) | 2.43775540 |
| 95 | Abnormal gallbladder physiology (HP:0012438) | 2.43775540 |
| 96 | Acanthocytosis (HP:0001927) | 2.43530309 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 2.38296724 |
| 98 | Hyperbilirubinemia (HP:0002904) | 2.37574359 |
| 99 | Congenital stationary night blindness (HP:0007642) | 2.36299725 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.36142774 |
| 101 | Ventricular fibrillation (HP:0001663) | 2.35132790 |
| 102 | Upper motor neuron abnormality (HP:0002127) | 2.33995482 |
| 103 | Increased mean platelet volume (HP:0011877) | 2.33872299 |
| 104 | Hyperventilation (HP:0002883) | 2.33271689 |
| 105 | Spontaneous abortion (HP:0005268) | 2.32256574 |
| 106 | Abnormal cartilage morphology (HP:0002763) | 2.32231674 |
| 107 | EMG: neuropathic changes (HP:0003445) | 2.30654071 |
| 108 | Generalized muscle weakness (HP:0003324) | 2.30445479 |
| 109 | Hydroxyprolinuria (HP:0003080) | 2.29436188 |
| 110 | Abnormality of proline metabolism (HP:0010907) | 2.29436188 |
| 111 | Broad nasal tip (HP:0000455) | 2.28564845 |
| 112 | Abnormality of the renal medulla (HP:0100957) | 2.27155894 |
| 113 | Conjugated hyperbilirubinemia (HP:0002908) | 2.26517738 |
| 114 | True hermaphroditism (HP:0010459) | 2.26087051 |
| 115 | Molar tooth sign on MRI (HP:0002419) | 2.25809587 |
| 116 | Abnormality of midbrain morphology (HP:0002418) | 2.25809587 |
| 117 | Genetic anticipation (HP:0003743) | 2.25385435 |
| 118 | Left ventricular hypertrophy (HP:0001712) | 2.24762377 |
| 119 | Gingival bleeding (HP:0000225) | 2.24480915 |
| 120 | Ventricular arrhythmia (HP:0004308) | 2.24304251 |
| 121 | Nephritis (HP:0000123) | 2.24248092 |
| 122 | Abnormality of the pons (HP:0007361) | 2.23009090 |
| 123 | Frequent falls (HP:0002359) | 2.22017851 |
| 124 | Malnutrition (HP:0004395) | 2.21690092 |
| 125 | Ulnar deviation of the wrist (HP:0003049) | 2.21310121 |
| 126 | Myotonia (HP:0002486) | 2.21223559 |
| 127 | Menorrhagia (HP:0000132) | 2.18500512 |
| 128 | Glomerulonephritis (HP:0000099) | 2.17393601 |
| 129 | Nephronophthisis (HP:0000090) | 2.16856810 |
| 130 | Polyuria (HP:0000103) | 2.15582515 |
| 131 | Hypoplasia of the pons (HP:0012110) | 2.15531616 |
| 132 | Abnormal platelet volume (HP:0011876) | 2.14211287 |
| 133 | Dilated cardiomyopathy (HP:0001644) | 2.13839847 |
| 134 | Rhabdomyolysis (HP:0003201) | 2.13706117 |
| 135 | Neck muscle weakness (HP:0000467) | 2.13050290 |
| 136 | Increased serum ferritin (HP:0003281) | 2.12836954 |
| 137 | Mitral stenosis (HP:0001718) | 2.12064299 |
| 138 | Thrombophlebitis (HP:0004418) | 2.11766557 |
| 139 | Tubulointerstitial fibrosis (HP:0005576) | 2.10515184 |
| 140 | Hemorrhage of the eye (HP:0011885) | 2.10235814 |
| 141 | Severe muscular hypotonia (HP:0006829) | 2.09120363 |
| 142 | Hyperkalemia (HP:0002153) | 2.08637925 |
| 143 | Ketoacidosis (HP:0001993) | 2.08178381 |
| 144 | Difficulty running (HP:0009046) | 2.03558364 |
| 145 | Attenuation of retinal blood vessels (HP:0007843) | 2.02950738 |
| 146 | Abnormality of serum amino acid levels (HP:0003112) | 2.01305626 |
| 147 | Myopathic facies (HP:0002058) | 2.00015700 |
| 148 | Decreased circulating renin level (HP:0003351) | 1.97164519 |
| 149 | Proximal tubulopathy (HP:0000114) | 1.97116802 |
| 150 | Axonal loss (HP:0003447) | 1.94625695 |
| 151 | Toxemia of pregnancy (HP:0100603) | 1.94071365 |
| 152 | Nausea (HP:0002018) | 1.93434921 |
| 153 | Sensorimotor neuropathy (HP:0007141) | 1.92598824 |
| 154 | Neonatal onset (HP:0003623) | 1.92231213 |
| 155 | Tetraparesis (HP:0002273) | 1.91001763 |
| 156 | Peritonitis (HP:0002586) | 1.90991401 |
| 157 | Metabolic acidosis (HP:0001942) | 1.90942431 |
| 158 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90842545 |
| 159 | Cholelithiasis (HP:0001081) | 1.90705947 |
| 160 | Facial diplegia (HP:0001349) | 1.90674532 |
| 161 | Hemiparesis (HP:0001269) | 1.89813655 |
| 162 | Progressive cerebellar ataxia (HP:0002073) | 1.89070937 |
| 163 | Rickets (HP:0002748) | 1.86006822 |
| 164 | Abnormal gallbladder morphology (HP:0012437) | 1.84942228 |
| 165 | Gaze-evoked nystagmus (HP:0000640) | 1.83935828 |
| 166 | Muscular dystrophy (HP:0003560) | 1.83688085 |
| 167 | Glomerulosclerosis (HP:0000096) | 1.83447518 |
| 168 | Generalized aminoaciduria (HP:0002909) | 1.83372931 |
| 169 | Abnormality of the Achilles tendon (HP:0005109) | 1.82205657 |
| 170 | Abnormal urine output (HP:0012590) | 1.81571917 |
| 171 | Increased purine levels (HP:0004368) | 1.80637862 |
| 172 | Hyperuricemia (HP:0002149) | 1.80637862 |
| 173 | Focal segmental glomerulosclerosis (HP:0000097) | 1.79585552 |
| 174 | Hypochromic microcytic anemia (HP:0004840) | 1.79469375 |
| 175 | Inability to walk (HP:0002540) | 1.78950117 |
| 176 | Pancreatitis (HP:0001733) | 1.78798993 |
| 177 | Palpitations (HP:0001962) | 1.78520859 |
| 178 | Abnormality of potassium homeostasis (HP:0011042) | 1.77916274 |
| 179 | Absent phalangeal crease (HP:0006109) | 1.77704878 |
| 180 | Prolonged QT interval (HP:0001657) | 1.77463452 |
| 181 | Protuberant abdomen (HP:0001538) | 1.76864142 |
| 182 | Hemiplegia (HP:0002301) | 1.76521168 |
| 183 | Pheochromocytoma (HP:0002666) | 1.76452165 |
| 184 | Delayed CNS myelination (HP:0002188) | 1.76423581 |
| 185 | Hematochezia (HP:0002573) | 1.75501899 |
| 186 | Fair hair (HP:0002286) | 1.73172953 |
| 187 | Abnormal biliary tract physiology (HP:0012439) | 1.73077483 |
| 188 | Alkalosis (HP:0001948) | 1.72450958 |
| 189 | Autoimmune thrombocytopenia (HP:0001973) | 1.72349619 |
| 190 | Reticulocytosis (HP:0001923) | 1.70696137 |
| 191 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.69123694 |
| 192 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.67945566 |
| 193 | Elevated alkaline phosphatase (HP:0003155) | 1.67262413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.46580958 |
| 2 | PINK1 | 3.73243522 |
| 3 | PNCK | 3.58553442 |
| 4 | ERN1 | 3.00594228 |
| 5 | PKN2 | 2.65102705 |
| 6 | PHKG1 | 2.60687493 |
| 7 | PHKG2 | 2.60687493 |
| 8 | FGFR4 | 2.56515249 |
| 9 | BMPR1B | 2.56329607 |
| 10 | TRIB3 | 2.52287103 |
| 11 | MAP3K10 | 2.37936819 |
| 12 | RIPK1 | 2.35912730 |
| 13 | SIK1 | 2.30499020 |
| 14 | TYK2 | 2.28934468 |
| 15 | STK10 | 2.12461944 |
| 16 | LATS1 | 2.08099239 |
| 17 | TTN | 2.07483851 |
| 18 | EEF2K | 2.07140085 |
| 19 | BCKDK | 2.05589106 |
| 20 | ADRBK2 | 2.04097879 |
| 21 | EPHA2 | 2.03356894 |
| 22 | MAP3K14 | 2.00715229 |
| 23 | TNIK | 1.91366175 |
| 24 | TAOK3 | 1.81193995 |
| 25 | PIK3CA | 1.78495268 |
| 26 | MST1R | 1.77410340 |
| 27 | ERBB4 | 1.75741345 |
| 28 | FLT3 | 1.72013905 |
| 29 | TBK1 | 1.69609570 |
| 30 | MAP4K1 | 1.67627820 |
| 31 | PTK6 | 1.66897120 |
| 32 | CAMKK2 | 1.66454779 |
| 33 | GRK7 | 1.66164498 |
| 34 | LRRK2 | 1.65624766 |
| 35 | JAK1 | 1.63976852 |
| 36 | GRK1 | 1.63152339 |
| 37 | BMX | 1.61362813 |
| 38 | NEK9 | 1.60877288 |
| 39 | NLK | 1.60543748 |
| 40 | TGFBR2 | 1.57516421 |
| 41 | SCYL2 | 1.54407711 |
| 42 | MAP3K3 | 1.52389293 |
| 43 | MAPK15 | 1.50792118 |
| 44 | MAP2K3 | 1.48764024 |
| 45 | CDK12 | 1.44996452 |
| 46 | CDK6 | 1.42882320 |
| 47 | STK3 | 1.35045190 |
| 48 | AKT3 | 1.33991357 |
| 49 | MUSK | 1.32341543 |
| 50 | PDGFRA | 1.28741656 |
| 51 | FRK | 1.25523920 |
| 52 | MAPKAPK3 | 1.23132498 |
| 53 | PIM1 | 1.22260713 |
| 54 | PIK3CG | 1.16427820 |
| 55 | MET | 1.15379098 |
| 56 | CSF1R | 1.12863909 |
| 57 | MAPK11 | 1.11469800 |
| 58 | GRK6 | 1.10953202 |
| 59 | TGFBR1 | 1.09662820 |
| 60 | JAK3 | 1.09110054 |
| 61 | DAPK2 | 1.06972812 |
| 62 | ITK | 1.06751437 |
| 63 | CAMK1D | 1.05290738 |
| 64 | JAK2 | 1.04562209 |
| 65 | TIE1 | 1.03268268 |
| 66 | MAP2K4 | 1.02071018 |
| 67 | PTK2B | 1.00329669 |
| 68 | PAK3 | 0.99099565 |
| 69 | INSRR | 0.98722521 |
| 70 | DMPK | 0.98026906 |
| 71 | CSK | 0.97855143 |
| 72 | MAPK13 | 0.97301607 |
| 73 | EPHB1 | 0.92525258 |
| 74 | CHUK | 0.91433270 |
| 75 | SGK2 | 0.90547748 |
| 76 | FGFR3 | 0.90436108 |
| 77 | IKBKB | 0.89478631 |
| 78 | PTK2 | 0.87023345 |
| 79 | IKBKE | 0.84184565 |
| 80 | MTOR | 0.83825316 |
| 81 | DYRK1B | 0.83767274 |
| 82 | MAPK12 | 0.81949445 |
| 83 | PRKAA1 | 0.81463043 |
| 84 | ADRBK1 | 0.80058796 |
| 85 | RPS6KA4 | 0.79193449 |
| 86 | BRSK2 | 0.79022120 |
| 87 | WNK3 | 0.78132159 |
| 88 | MAP3K7 | 0.77587853 |
| 89 | MYLK | 0.76262969 |
| 90 | ABL2 | 0.75402510 |
| 91 | MAP3K8 | 0.75382588 |
| 92 | ZAP70 | 0.74490495 |
| 93 | RPS6KB2 | 0.74115726 |
| 94 | TRPM7 | 0.73885165 |
| 95 | MAP2K2 | 0.72563719 |
| 96 | WNK1 | 0.71982908 |
| 97 | PAK2 | 0.71926765 |
| 98 | TSSK6 | 0.71498304 |
| 99 | BTK | 0.70496450 |
| 100 | MOS | 0.70372769 |
| 101 | KIT | 0.69147751 |
| 102 | CDK4 | 0.68046082 |
| 103 | CAMK1G | 0.67906163 |
| 104 | GSK3A | 0.66229260 |
| 105 | KDR | 0.66079400 |
| 106 | CASK | 0.65557779 |
| 107 | MAP3K2 | 0.64524605 |
| 108 | MARK3 | 0.63265272 |
| 109 | CAMK1 | 0.62817695 |
| 110 | PIM2 | 0.61999620 |
| 111 | MAP2K6 | 0.61221778 |
| 112 | EGFR | 0.60706630 |
| 113 | CAMK4 | 0.60270030 |
| 114 | MAPK4 | 0.59927373 |
| 115 | NEK2 | 0.59215506 |
| 116 | MARK1 | 0.56940577 |
| 117 | MAP3K4 | 0.56897905 |
| 118 | IRAK1 | 0.55748924 |
| 119 | TXK | 0.55035577 |
| 120 | STK39 | 0.54757076 |
| 121 | PDK2 | 0.54586467 |
| 122 | STK24 | 0.54527343 |
| 123 | EPHA3 | 0.54175515 |
| 124 | TYRO3 | 0.54143853 |
| 125 | PRKCE | 0.53909004 |
| 126 | MAP3K11 | 0.53387105 |
| 127 | WNK4 | 0.53265425 |
| 128 | NUAK1 | 0.52939126 |
| 129 | PRKCQ | 0.52130849 |
| 130 | CAMK2D | 0.52094231 |
| 131 | SGK223 | 0.51813105 |
| 132 | SGK494 | 0.51813105 |
| 133 | ACVR1B | 0.50559799 |
| 134 | PDGFRB | 0.50154983 |
| 135 | MAP4K2 | 0.49956320 |
| 136 | PRKACA | 0.49590233 |
| 137 | TEC | 0.48653958 |
| 138 | HCK | 0.48390909 |
| 139 | MATK | 0.47222797 |
| 140 | STK38L | 0.46972642 |
| 141 | SGK3 | 0.44827586 |
| 142 | MAP2K1 | 0.44541368 |
| 143 | IGF1R | 0.43728504 |
| 144 | ABL1 | 0.43646722 |
| 145 | OXSR1 | 0.42370257 |
| 146 | PRKAA2 | 0.42048132 |
| 147 | NEK1 | 0.41972237 |
| 148 | STK4 | 0.41328183 |
| 149 | STK11 | 0.40770835 |
| 150 | NTRK3 | 0.40228569 |
| 151 | TNK2 | 0.39140392 |
| 152 | PDK3 | 0.38863843 |
| 153 | PDK4 | 0.38863843 |
| 154 | BLK | 0.38173486 |
| 155 | RET | 0.36729908 |
| 156 | RPS6KA6 | 0.36723387 |
| 157 | PRKG1 | 0.36689945 |
| 158 | INSR | 0.36529148 |
| 159 | MAPK7 | 0.35692500 |
| 160 | SYK | 0.34961189 |
| 161 | PAK4 | 0.34734498 |
| 162 | PRKACG | 0.34045774 |
| 163 | FER | 0.33988301 |
| 164 | CAMK2A | 0.33830773 |
| 165 | FGFR1 | 0.32958471 |
| 166 | PRKCG | 0.32447914 |
| 167 | LCK | 0.32376182 |
| 168 | PDK1 | 0.31615857 |
| 169 | ROCK1 | 0.31341726 |
| 170 | ERBB2 | 0.30543066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.94562687 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.63369293 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48809193 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96378084 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.84869077 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.65889467 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.60636083 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.59597333 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.51131578 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.42675644 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.39168570 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.38885915 |
| 13 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.36273173 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34470815 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.10650758 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.10047939 |
| 17 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.08076124 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.03194150 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.00303524 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.99559168 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.99353204 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86298678 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.82926470 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.82325295 |
| 25 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.80998199 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80884627 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75701576 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.74372845 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.73630466 |
| 30 | Circadian rhythm_Homo sapiens_hsa04710 | 1.73527075 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.67907009 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.63622919 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.62455508 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60035437 |
| 35 | Phototransduction_Homo sapiens_hsa04744 | 1.55098320 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.52826131 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.51678717 |
| 38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.50111152 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.45377733 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.45138024 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.37977610 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34331934 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.33930559 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.31046766 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27197766 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.24581126 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.23695147 |
| 48 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.22479855 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21594879 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16995003 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.14746701 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 1.14668800 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.14286070 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13935719 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.12084457 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04310593 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.03220938 |
| 58 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.02451128 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99923570 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.98494498 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.96377759 |
| 62 | Insulin secretion_Homo sapiens_hsa04911 | 0.95729084 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.93909003 |
| 64 | Salivary secretion_Homo sapiens_hsa04970 | 0.92403064 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91282481 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90612448 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90517197 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88126093 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88052337 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.87020502 |
| 71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.86674079 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86667059 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84299469 |
| 74 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.83484285 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82510624 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81876767 |
| 77 | Renin secretion_Homo sapiens_hsa04924 | 0.80418254 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.77981780 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.75836944 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73144274 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.72498151 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72151743 |
| 83 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70742254 |
| 84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70447729 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.69302998 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.65416709 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64801790 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63535118 |
| 89 | Taste transduction_Homo sapiens_hsa04742 | 0.60513219 |
| 90 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59961721 |
| 91 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.57816164 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56981068 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.53615032 |
| 94 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.52488393 |
| 95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52107610 |
| 96 | Circadian entrainment_Homo sapiens_hsa04713 | 0.51700268 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.51190783 |
| 98 | Olfactory transduction_Homo sapiens_hsa04740 | 0.48964106 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.48872328 |
| 100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48702197 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.47409567 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46664068 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45048531 |
| 104 | Leishmaniasis_Homo sapiens_hsa05140 | 0.43124043 |
| 105 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42880128 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42456489 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41688701 |
| 108 | Morphine addiction_Homo sapiens_hsa05032 | 0.40636026 |
| 109 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40437886 |
| 110 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40330915 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39808918 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.39270256 |
| 113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39012302 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38921725 |
| 115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.38921428 |
| 116 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38451381 |
| 117 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38375703 |
| 118 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38215583 |
| 119 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.37394567 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36862164 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34516710 |
| 122 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.32782081 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.30965544 |
| 124 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30962006 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.30956930 |
| 126 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30545263 |
| 127 | Pertussis_Homo sapiens_hsa05133 | 0.29319537 |
| 128 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28165433 |
| 129 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.25623070 |
| 130 | Malaria_Homo sapiens_hsa05144 | 0.25098385 |
| 131 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.24200045 |
| 132 | Hepatitis C_Homo sapiens_hsa05160 | 0.22527084 |
| 133 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.22442383 |
| 134 | Lysosome_Homo sapiens_hsa04142 | 0.22185140 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19961061 |
| 136 | Apoptosis_Homo sapiens_hsa04210 | 0.18007989 |
| 137 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.17527157 |
| 138 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.17287380 |
| 139 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16624968 |
| 140 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.16186529 |
| 141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15639435 |
| 142 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.15556182 |
| 143 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.13988007 |
| 144 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.13154647 |
| 145 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.12777410 |
| 146 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.12129098 |
| 147 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.10501557 |
| 148 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.10378432 |
| 149 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09606868 |
| 150 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.09007614 |

